Wey L Leong Selected Research

Wey L Leong Research Topics

7	Neoplasms (Cancer) 12/2021 - 03/2002
7	Breast Neoplasms (Breast Cancer) 12/2021 - 09/2004
3	Melanoma (Melanoma, Malignant) 11/2018 - 03/2003
2	Neoplasm Metastasis (Metastasis) 01/2012 - 02/2007
1	Ovarian Neoplasms (Ovarian Cancer) 11/2018
1	Carcinogenesis 01/2012
1	Lymphatic Metastasis 01/2012
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2007
1	Ductal Carcinoma 09/2004
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 09/2004
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 09/2004
1	Carcinoid Tumor (Carcinoid) 03/2002
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2002

1	ProdrugsIBA 12/2021
1	AcidsIBA 12/2021
1	Aminolevulinic Acid (Levulan)FDA Link 12/2021
1	PorphyrinsIBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Insulin ReceptorIBA 03/2015
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 03/2015
1	Insulin (Novolin)FDA Link 03/2015
1	Blood Glucose (Blood Sugar)IBA 03/2015
1	Organic Cation Transporter 1IBA 03/2015
1	Mitogen-Activated Protein Kinase 3IBA 03/2015
1	Metformin (Glucophage)FDA LinkGeneric 03/2015
1	Acetyl-CoA CarboxylaseIBA 03/2015
1	AntibodiesIBA 02/2015
1	CaveolinsIBA 05/2012
1	ClaudinsIBA 05/2012
1	Phenobarbital (Luminal)FDA Link 05/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	DecorinIBA 01/2012
1	endoplasminIBA 01/2012
1	ParaffinIBA 06/2011
1	Formaldehyde (Formol)FDA Link 06/2011
1	DNA (Deoxyribonucleic Acid)IBA 06/2011
1	RNA (Ribonucleic Acid)IBA 06/2011
1	ANNA-2 antibodyIBA 09/2004
1	Octreotide (Sandostatin)FDA LinkGeneric 03/2002
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2002

3	Therapeutics 03/2015 - 03/2002
2	Lymph Node Excision (Lymph Node Dissection) 02/2007 - 02/2007
1	Immunotherapy 11/2018
1	Aftercare (After-Treatment) 03/2015
1	Mastectomy (Mammectomy) 02/2007
1	Simple Mastectomy 09/2004
1	Contraindications 03/2003
1	Palliative Care (Palliative Therapy) 03/2002